Quick Answer
Organogenesis Holdings Inc. reported Stockholders Equity of $300.13 million for fiscal year 2025.
Organogenesis Holdings Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $300.13M | +14.2% |
| 2024 | $262.90M | -5.7% |
| 2023 | $278.66M | +4.9% |
| 2022 | $265.67M | +10.0% |
| 2022 | $241.53M | +0.1% |
| 2021 | $241.34M | +70.2% |
| 2020 | $141.81M | +172.6% |
| 2019 | $52.02M | +30.3% |
| 2018 | $39.94M | +360.7% |
| 2017 | -$15.32M | +4.1% |
| 2016 | -$15.98M | -554.7% |
| 2015 | $3.51M | — |
| 2015 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $255.13M | -8.4% | +9.4% |
| June 30, 2025 | $233.24M | -11.5% | -4.0% |
| March 31, 2025 | $242.90M | -12.6% | -7.6% |
| December 31, 2024 | $262.90M | -5.7% | -5.6% |
| September 30, 2024 | $278.55M | +0.6% | +5.7% |
| June 30, 2024 | $263.50M | -2.9% | -5.2% |
| March 31, 2024 | $278.03M | +5.4% | -0.2% |
| December 31, 2023 | $278.66M | +4.9% | +0.6% |
- Organogenesis Holdings Inc. showed an increase of +14.2% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Organogenesis Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: